T1	Participants 82 117	patients with chronic heart failure
T2	Participants 331 366	Nineteen patients entered the study
T3	Participants 368 594	Three patients had ischemic heart disease, 13 had dilated cardiomyopathy, and three had valvular disease; 16 patients were in New York Heart Association class II, and three patients were in New York Heart Association class III
